These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 28284536)

  • 1. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
    Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent nasal symptoms and mediator release after continuous pollen exposure in an environmental challenge chamber.
    Okuma Y; Okamoto Y; Yonekura S; Iinuma T; Sakurai T; Hamasaki S; Ohki Y; Yamamoto H; Sakurai D
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):150-7. PubMed ID: 27263086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity.
    Baumann R; Rabaszowski M; Stenin I; Tilgner L; Gaertner-Akerboom M; Scheckenbach K; Wiltfang J; Chaker A; Schipper J; Wagenmann M
    Clin Exp Allergy; 2013 Oct; 43(10):1134-43. PubMed ID: 24074331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive nasal allergen challenge in allergic rhinitis: Priming and Th2-type inflammation but no evidence of remodelling.
    Orban NT; Jacobson MR; Nouri-Aria KT; Durham SR; Eifan AO
    Clin Exp Allergy; 2021 Feb; 51(2):329-338. PubMed ID: 33141493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal nitric oxide measurements in the assessment of nasal allergen challenge.
    Tworek D; Kuna P
    J Investig Allergol Clin Immunol; 2012; 22(2):102-8. PubMed ID: 22533232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
    Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of melanocortin 1 receptor in allergic rhinitis in vitro and in vivo.
    Kleiner S; Braunstahl GJ; Rüdrich U; Gehring M; Eiz-Vesper B; Luger TA; Steelant B; Seys SF; Kapp A; Böhm M; Hellings PW; Raap U
    Clin Exp Allergy; 2016 Aug; 46(8):1066-74. PubMed ID: 27196703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
    Krug N; Gupta A; Badorrek P; Koenen R; Mueller M; Pivovarova A; Hilbert J; Wetzel K; Hohlfeld JM; Wood C
    J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
    Greiff L; Petersen H; Mattsson E; Andersson M; Erjefält JS; Linden M; Svensson C; Persson CG
    Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.
    Scadding GW; Eifan AO; Lao-Araya M; Penagos M; Poon SY; Steveling E; Yan R; Switzer A; Phippard D; Togias A; Shamji MH; Durham SR
    Allergy; 2015 Jun; 70(6):689-96. PubMed ID: 25773990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal lavage mediator profile and cellular composition of nasal brushing material during latex challenge tests.
    Raulf-Heimsoth M; Wirtz C; Papenfuss F; Baur X
    Clin Exp Allergy; 2000 Jan; 30(1):110-21. PubMed ID: 10606938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge.
    Erin EM; Leaker BR; Zacharasiewicz AS; Higgins LA; Williams TJ; Boyce MJ; de Boer P; Durham SR; Barnes PJ; Hansel TT
    Allergy; 2005 Dec; 60(12):1524-9. PubMed ID: 16266385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability and reproducibility of biomarkers for the evaluation of anti-inflammatory therapy in allergic rhinitis.
    Boot JD; Chandoesing P; de Kam ML; Mascelli MA; Das AM; Gerth van Wijk R; de Groot H; Verhoosel R; Hiemstra PS; Diamant Z
    J Investig Allergol Clin Immunol; 2008; 18(6):433-42. PubMed ID: 19123434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary study on Japanese cedar pollinosis in an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K; Tang H; Fujita T; Tsubaki S; Fujita M; Suematsu K; Gotoh M; Okubo K
    Allergol Int; 2007 Jun; 56(2):125-30. PubMed ID: 17384532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pollen derived low molecular compounds enhance the human allergen specific immune response in vivo.
    Gilles-Stein S; Beck I; Chaker A; Bas M; McIntyre M; Cifuentes L; Petersen A; Gutermuth J; Schmidt-Weber C; Behrendt H; Traidl-Hoffmann C
    Clin Exp Allergy; 2016 Oct; 46(10):1355-65. PubMed ID: 27061126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
    Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
    Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of laryngeal symptoms induced in patients with allergic rhinitis in an environmental challenge chamber.
    Suzuki T; Okamoto Y; Yonekura S; Okuma Y; Sakurai T; Sakurai D
    Ann Allergy Asthma Immunol; 2016 Jun; 116(6):491-6. PubMed ID: 27048949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.
    Scadding GW; Calderon MA; Bellido V; Koed GK; Nielsen NC; Lund K; Togias A; Phippard D; Turka LA; Hansel TT; Durham SR; Wurtzen PA
    J Immunol Methods; 2012 Oct; 384(1-2):25-32. PubMed ID: 22759401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.